Your browser doesn't support javascript.
The management of dialysis access thrombosis during the COVID-19 pandemic.
Seet, Christopher; Lindsey, Ben; Sivaprakasam, Rajesh; McCafferty, Kieran; Forbes, Suzanne; Akhtar, Mohammed Rashid; Khurram, Muhammad; Mohamed, Ismail H.
  • Seet C; Department of Nephrology and Transplantation, The Royal London Hospital, Bart's Health NHS Trust, London, UK.
  • Lindsey B; Department of Nephrology and Transplantation, The Royal London Hospital, Bart's Health NHS Trust, London, UK.
  • Sivaprakasam R; Department of Nephrology and Transplantation, The Royal London Hospital, Bart's Health NHS Trust, London, UK.
  • McCafferty K; Department of Nephrology and Transplantation, The Royal London Hospital, Bart's Health NHS Trust, London, UK.
  • Forbes S; Department of Nephrology and Transplantation, The Royal London Hospital, Bart's Health NHS Trust, London, UK.
  • Akhtar MR; Department of Interventional Radiology, The Royal London Hospital, Bart's Health NHS Trust, London, UK.
  • Khurram M; Department of Nephrology and Transplantation, The Royal London Hospital, Bart's Health NHS Trust, London, UK.
  • Mohamed IH; Department of Nephrology and Transplantation, The Royal London Hospital, Bart's Health NHS Trust, London, UK.
J Vasc Access ; : 11297298211045578, 2021 Sep 18.
Article in English | MEDLINE | ID: covidwho-1430354
ABSTRACT

BACKGROUND:

Maintaining patent access is essential for haemodialysis dependent end stage renal failure patients. The COVID-19 pandemic has significantly affected surgical and interventional radiology services worldwide. We aimed to review the impact COVID-19 has caused to the management of acute dialysis access thrombosis.

METHODS:

We conducted a single centre retrospective review of outcomes of patients with arteriovenous fistula and arteriovenous graft thrombosis between March and May 2020, which coincided with the first peak of the COVID-19 pandemic in London, and a similar period in the previous year, March-May 2019. Outcomes in both cohorts of patients were compared, including attempts at salvage, salvage success, 1-month patency rates after salvage and subsequent surgery on the same access. We also analysed the use of tunnelled haemodialysis lines (THL), either due to failed salvage attempts or when salvage was not attempted.

RESULTS:

There was a similar incidence of access thrombosis in both periods (26 cases in 2019, 38 in 2020). There were 601 patients dialysing via an arteriovenous fistula or graft in 2019, and 568 patients in 2020. Access salvage, when attempted, had similar success rates and 1-month patency (salvage success 74% vs 80%, p = 0.39; 1-month patency 55% vs 62%, p = 0.69). The proportion of patients where access salvage was not attempted and a THL inserted was significantly higher in 2020 compared to 2019 (32% vs 4%, p = 0.007). There were more patients who subsequently had surgery to salvage or revise the same access in 2019 compared to 2020 (62% vs 13%, p < 0.001).

CONCLUSIONS:

During the peak of the COVID-19 pandemic, there were fewer attempts at access salvage. This was a conscious decision due to increased pressure on the healthcare system, access to emergency interventional radiology or operative theatres and the perceived risk/benefit ratio of access salvage. The long-term effects of this change in practice remain unknown.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Observational study / Prognostic study Language: English Journal: J Vasc Access Journal subject: Vascular Diseases Year: 2021 Document Type: Article Affiliation country: 11297298211045578

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Observational study / Prognostic study Language: English Journal: J Vasc Access Journal subject: Vascular Diseases Year: 2021 Document Type: Article Affiliation country: 11297298211045578